Metabolic Reprogramming of Trophoblast Cells in Response to Hypoxia
Hypoxia of trophoblast cells is an important regulator of normal development of the placenta. However, some pathological states associated with hypoxia, e.g. preeclampsia, impair the functions of placental cells. Oxyquinoline derivative inhibits HIF-prolyl hydroxylase by stabilizing HIF-1 transcription complex, thus modeling cell response to hypoxia. In human choriocarcinoma cells BeWo b30 (trophoblast model), oxyquinoline increased the expression of a core hypoxia response genes along with up-regulation of NOS3, PDK1, and BNIP3 genes and down-regulation of the PPARGC1B gene. These changes in the expression profile attest to activation of the metabolic cell reprogramming mechanisms aimed at reducing oxygen consumption by enabling the switch from aerobic to anaerobic glucose metabolism and the respective decrease in number of mitochondria. The possibility of practical use of the therapeutic properties of oxyquinoline derivatives is discussed.
Key WordsBeWo b30 placenta hypoxia oxyquinoline barrier
Unable to display preview. Download preview PDF.
- 5.Knyazev EN, Mal’tseva DV, Zacharyants AA, Zakharova GS, Zhidkova OV, Poloznikov AA. TNFα-induced expression of transport protein genes in HUVEC cells is associated with enhanced expression of transcription factor genes RELB and NFKB2 of the non-canonical NF-κB Pathway. Bull. Exp. Biol. Med. 2018;164(6):757-761.CrossRefGoogle Scholar
- 9.Osipyants AI, Smirnova NA, Khristichenko AY, Hushpulian DM, Nikulin SV, Chubar TA, Zakhariants AA, Tishkov VI, Gazaryan IG, Poloznikov AA. Enzyme-substrate reporters for evaluation of substrate specificity of HIF prolyl hydroxylase isoforms. Biochemistry (Mosc). 2017;82(10):1207-1214.CrossRefGoogle Scholar
- 14.Smirnova NA, Kaidery NA, Hushpulian DM, Rakhman II, Poloznikov AA, Tishkov VI, Karuppagounder SS, Gaisina IN, Pekcec A, Leyen KV, Kazakov SV, Yang L, Thomas B, Ratan RR, Gazaryan IG. Bioactive flavonoids and catechols as Hif1 and Nrf2 protein stabilizers — implications for Parkinson’s disease. Aging Dis. 2016;7(6):745-762.CrossRefGoogle Scholar